Abstract
The actions of bradykinin, kallidin, and related substances are, of necessity, assayed primarily on smooth muscle since at present this is the only way to quantitatively assess potency. Thus most of the published literature on these polypeptides refers, in part, to their actions on smooth muscle. This section deals primarily in modes of action on smooth muscle and includes the antagonists and potentiators of the kinins on smooth muscle. Bioassay techniques and activity comparisons with other kinins are covered elsewhere.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Aarsen, P. N.: Sensitization of guinea-pig ileum to the action of bradykinin by trypsin hydrolysate of ox and rabbit plasma. Brit. J. Pharmacol. 32, 453 (1968).
Ambache, N., Rocha E Silva, M.: Analysis of certain interactions of nicotine with brady kinin and histamine. Brit. J. Pharmacol. 6, 68 (1951).
Antonio, A.: The relaxing effect of bradykinin on intestinal smooth muscle. Brit. J. Pharmacol. 32, 78 (1968).
Auerswald, W., Doleschrt. W.: On the potentiation of kinins by sulfhydrylic compounds. Arch. int. Pharmacodyn. 168, 188 (1967).
Bauer, G., Gmeiner, R., Winkler, H.: Über die Wirkung synthetischer Polypeptide auf den Darm in situ. Arch. hit. Pharmacodyn. 159, 373 (1966a).
Bauer, G., Ziegler, E., Koxzett, H.: Zur Hemmwirkung von Kininen and isolierten Darmpräparaten. Naunyn-Schmiedebergs Arch. exp. Path. Pharmak. 254, 235 (1966b).
Beleslin, D. B., Bogadnovic, S. BI., Radmanovic, B. Z.: The possible site of action of bradykinin on the peristaltic reflex of the isolated guinea pig ileum. Arch. int. Pharmacodyn. 147, 43 (1964).
Berde, B., Saameli, K.: Effect of bradykinin on uterine activity. Nature (Lond.) 191, 83 (1961).
Bhoola, K. D., Collier, H. O. J., Schachter, M., Shorley, P. G.: Actions of some peptides on bronchial muscle. Brit. J. Pharmacol. 19, 190 (1962).
Bisset, G. W., Clark, B. J., Haldar, J., Harris, M. C., Lewis, G. P., Rocha E Silva, M.: The assay of milk-ejecting activity in the lactating rat. Brit. J. Pharmacol. 31, 537 (1967).
Bisset, G. W., Lewis, G. P.: A spectrum of pharmacological activity in some biological active peptides. Brit. J. Pharmacol. 19, 168 (1962).
Capek, R., Knesslova, V.: Die Wirkung von TEAE auf die Bradykininkontraktion des isolierten Rattenuterus. Naunyn-Schmiedebergs Arch. exp. Path. Pharmak. 236, 161 (1959).
Carroll, P. R., Starmer, G. A.: Studi s on the pharmacology of conopharyngine, an indole alkaloid of the voacanga series. Brit. J. Pharmacol. 30, 173 (1967).
Catacutan-Labay, P., Boyarsky, S.: Effect on ureteral peristalsis. Science 151, 78 (1966).
Cerletti, A., Stürmer, E., Konzett, H.: Bradykinin: Information on its structure, synthesis, and physiologic-pharmacological basis. Dtsch. med. Wschr. 86, 678 (1961).
Cirstea, M.: Potentiation of some bradykinin effects by thiol compounds. Brit. J. Pharmacol. 25, 405 (1965).
Collier, H. O. J.: Antagonists of bradykinin. Biochem. Pharmacol. 10, 47 (1962).
Collier, H. O. J., Holgate, J. A., Schachter, M., Shorley, P. G.: The bronchoconstrictor action of bradykinin in the guinea-pig. Brit. J. Pharmacol. 15, 290 (1960).
Collier, H. O. J., Shorley, P. G.: Analgesic antipyretic drugs as antagonists of bradykinin. Brit. J. Pharmacol. 15, 601 (1960).
Day, M., Vane, J. R.: An analysis of the direct and indirect actions of drugs on the isolated guinea pig ileum. Brit. J. Pharmacol. 20, 150 (1963).
Edery, H.: Potentiation of the action of bradykinin on smooth muscle by chymotrypsin and trypsin. Brit. J. Pharmacol. 22, 371 (1964).
Edery, H.: Further studies of the sensitization of smooth muscle to the action of plasma kinins by proteolytic enzymes. Brit. J. Pharmacol. 24, 485 (1965).
Ehrenpreiss, S., Fleisch, J. H.: Alteration in vasoactive polypeptide receptor activity of rat fundal strip by heat and urea. Fed. Proc. 27, 70 (1968).
Elliott, D. F., Horton, E. W., Lewis, G. P.: Actions of pure bradykinin. J. Physiol. (Lond.) 153, 473 (1960).
Erdös, E. G., Wohler, J R: Inhibitors of the “in vivo” effects of bradykinin and kallidin. Life Sci. 2, 270 (1963a).
Erdös, E. G., Wohler, J R: Inhibition “in vivo” of the enzymatic inactivation of bradykinin and kallidin. Biochem. Pharmacol. 12, 1193 (1963b).
Erdös, E. G., Wohler, J R, Levine, M. I.: Blocking of the “in vivo” effects of bradykinin and kallidin with carboxypeptidase B. J. Pharmacol. exp. Ther. 142, 327 (1963).
Erspammer, V., Erspamer, G. F.: Pharmacological actions of eledoisin on extravascular smooth muscle. Brit. J. Pharmacol. 19, 337 (1962).
Felix, J.: A clinical and experimental study of the action of tissue extracts on the circulatory system: An experimental study of the action of Padutin (kallikrein). Acta med. scand. 83, 328 (1934).
Ferreira, SH: A bradykinin-potentiating factor (BPF) present in the venom of Bothrops jararaca. Brit. J. Pharmacol. 24, 163 (1965).
Ferreira, SH, Rocha E Silva, M.: Potentiation of bradykinin by dimercaptopropanol (BAL) and other inhibitors of its destroying enzyme in plasma. Biochem. Pharmacol. 11, 1123 (1962).
Ferreira, SH, Rocha E: Potentiation of bradykinin and eledoisin by BPF (bradykinin potentiating factor) from Bothrops jararacavenom. Experientia (Basel) 21, 347 (1965).
Ferreira, SH, Vane, J. R.: The detection and estimation of bradykinin in the circulating blood. Brit. J. Pharmacol. 29, 367 (1967).
Fishlock, D. J.: Effect of bradykinin on the human isolated small and large intestine. Nature (Lond.) 212, 1533 (1966).
Fregnan, G. B., Glässer, A. H.: Activity of eledoisin, other polypeptides and ergometrine on the uterus in situof rabbit and other animal species. J. Pharm. Pharmacol. 16, 744 (1964).
Frey, E. K., Kraut, H.: Ein neues Kreislaufhormon and seine Wirkung. Naunyn-Scbmiedebergs Arch. exp. Path. Pharmak. 133, 1 (1928).
Gm:mum, J. H., HORTON, E. W.: The extraction of human urinary kinin (Substance Z) and its relation to the plasma kinins. Brit. J. Pharmacol. 14 117 (1959).
Gershon, M. D.: Effects of tetrodotoxin on innervated smooth muscle preparations. Brit. J. Pharmacol. 29, 259 (1967).
Griiron., T. M., Kelly, C. A.: Mechanism of action of chymotrypsin on plain muscle. Brit. J. Pharmacol. 27, 120 (1966).
Gladner, J. A.: Potentiation of the effect of bradykinin In: Hypotensive peptides, p. 344, ed. by E. G. Erdös, N. Back, and F. Sicuteri. Berlin-Heidelberg-New York: Springer 1966.
Gladner, J. A., Murtaugu, P. A., Folk, J. E., Lake, K.: Nature of peptides released by thrombin. Ann. N.Y. Acad. Sci. 104, 47 (1963).
Gokhale, S D, Gulati, O. D., Kelkar, L. V., Kelkar, V. V.: Effect of some drugs on human umbilical artery in vitro. Brit. J. Pharmacol. 27, 332 (1966).
Graham, J. D. P., AL Kilns, H.: The effect of 2-halogenoalkylamines on the biological activity of some peptides. Brit. J. Pharmacol. 27, 377 (1966).
Gulate, O. D., Parsxh, H. M., Um/tit, M. S.: Receptors for noradrenaline and histamine in the rabbit’s posterior vena cava. Brit. J. Pharmacol. 32, 87 (1968).
Ramberg, U.: Structure and biological activity of bradykinin. Ann. Acad. Sci. fenn. 106, 12 (1964).
Ramberg, U., Elg, P., Stelwagen, P.: On the mechanism of bradykinin potentiation. In: Advances in experimental medicine and biology, pharmacology of hormonal polypeptides and proteins, vol. 2, p. 626, ed. by N. Back, L. Martini, and R. Paolettl. New York: Plenum Press 1968.
Horton, E. W.: Human urinary kinin excretion. Brit. J. Pharmacol. 14, 125 (1959).
Huggars, C. G., Walaszek, E. J.: Depressor polypeptides. Amer. Heart J. 60, 976 (1960).
Huidobro, H. V.: The role of calcium in the effect of bradykinin on smooth muscle. Biochem. Pharmacol. 12(Suppl.), 180 (1963).
Kraraat.T.AH, P A, Page, I. H.: Mechanism of action of angiotensin and bradykinin on smooth muscle in situ. Amer J Physiol. 200, 51 (1961).
Kraraat.T.AH, P A, Page, I. H.: Effects of bradykinin and angiotensin on smooth muscle. Ann. N.Y. Acad. Sci. 104, 212 (1963).
Klupp, H., Konzett, H.: Der Einfluß von Bradykinin und Kallidin auf den Druck in der Arteria pulmonalis. Naunyn-Schmiedebergs Arch. exp. Path. Pharmak. 249, 479 (1965).
Konzetr, H., STÜRmer, E.: Biological activity of synthetic polypeptides with bradykinin-like properties. Brit. J. Pharmacol. 15, 544 (1960).
Kovacs, B. A., MELVrr LE, K. I.: Antihistamine and antibradykinin effects of normal urine extracts. Nature (Lond.) 198, 1060 (1963).
Kovalcik, V.: Effect of bradykinin on isolated coronary arteries. Nature (Lond.) 196, 174 (1962).
Laborit, H., Leterrier, F., Massart, A., Baron, C.: Contribution à l’étude pharmacologique de la Padutine (Kallikreine pancreatique). Agressologie 5, 623 (1964).
Lembeck, F., Fisuhlra, G.: Gekreurte Tachyphylaxie von Peptiden. Naunyn-Schmiedebergs Arch. exp. Path. Pharmak. 258, 452 (1967).
Leme, J. G., Rocha E Silve, M.: Competitive and non-competitive inhibition of bradykinin on the guinea pig ileum. Brit. J. Pharmacol. 25, 50 (1965).
Leme, J. G., Walaszek, E. J.: Antagonists of pharmacologically active polypeptides: Effects on guinea pig ileum and inflammation. Pharmacologist 7, No 2, 242 (1967).
Levy, B.: The intestinal inhibitory response to oxytocin, vasopressin and bradykinin. J. Pharmacol. exp. Ther. 140, 356 (1963).
Marian, L.: Drugs antagonistic to bradykinin. Boll. Soc. ital. Biol. sper. 37, 1481 (1961).
Mcgrat, W. R., Lewis, R. E., Kumc, W. L.: The dual mode of the antispasmodic effect of dicyclomine hydrochloride. J. Pharmacol. exp. Ther. 146, 354 (1964).
Middleton, E., JR., PmLres, G. B.: Effects of lysolecithin on the smooth muscle stimulating activity of histamine, acetylcholine, 5-HT, anaphylactic, slow-reacting substance and bradykinin Nature (Lond.) 198, 758 (1963).
Montgomery, E. H.: The response of the rat duodenum to bradykinin. Proc. Western Pharmacol. Soc. 11, 51 (1968).
Paton, W. D. M.: Compound 48/80: A potent histamine liberator. Brit. J. Pharmacol. 6, 499 (1951).
Picarelli, Z P, Henriques, O. B., Oliveira, M. C.: Potentiation of bradykinin action on smooth-muscle by cysteine. Experientia (Basel) 18, 77 (1962).
Poisner, A. M., Douglas, W. W.: The need for calcium in adrenomedullary secretion evoked by biogenic amines, polypeptides, and muscarinic agents. Proc. Soc. exp. Biol. (N.Y.) 123, 62 (1966).
Potter, D. E., Walaszek, E. J.: Potentiation of the bradykinin response by cysteine: Mechanism of action. Fed. Proc. 27, 662 (1968).
Riezen, H. Van: Methixene: A non-competitive antagonist of bradykinin. J. Pharm. Pharmacol. 18, 688 (1966).
Rocha E Silva, M.: Definition of bradykinin and other kinins. Biochem. Pharmacol. 10, 3 (1962).
Rocha E Beraldo, W. T., Rosenfeld, G.: Bradykinin, a hypotensive and smooth muscle stimulating factor released from plasma globulin by snake venom and trypsin. Amer. J. Physiol. 156, 261 (1949).
Rocha E Leme, J. G.: Antagonists of bradykinin. Med. exp. (Basel) 8, 287 (1963).
Rocha E Leme, J. G.: On some antagonists of bradykinin. Naunyn-Schmiedebergs Arch. exp. Path. Pharmak. 250, 167 (1964).
Rocha E Leme, J. G.: Antagonists of bradykinin In: Recent advances in the pharmacology of toxins. Proc. II. Internat. Pharmacol. Congr., vol. 9, p. 33, ed. by Helena Raskova. Oxford: Pergamon Press 1965.
Schachter, M.: A delayed contracting effect of serum and plasma due to the release of a substance resembling kallidin and bradykinin. Brit. J. Pharmacol. 11, 111 (1956).
Shorley, P. G., Collier, H. O. J.: Direct comparisons of the synthetic nonapeptide with trypsin bradykinin. Nature (Lond.) 188, 999 (1960).
Smita, C. M., Walaszek, E. J.: Interaction of substance P and other smooth muscle stimulants with LSD-25 on the guinea pig ileum. Arch. int. Pharmacodyn. 138, 429 (1962).
Stewart, J. M.: Structure-activity relationships in bradykinin-analogues. Fed. Proc. 27, 63 (1968).
Stewart, J. M., Woolley, D. W.: Threonine analogs of bradykinin designed as antimetabolites. Biochemistry 3, 700 (1964).
Stewart, J. M., Woolley, D. W.: The search for peptides with specific anti-bradykinin activity. Biochem. Pharmacol. 14, 1399 (1965).
Stiirmer, E. Berde, B.: A pharmacological comparison between synthetic bradykinin and synthetic kallidin. J. Pharmacol. exp. Ther. 139, 38 (1963a).
Stiirmer, E. Berde, B.: A comparative pharmacological study of synthetic eledoisin and synthetic bradykinin J. Pharmacol. exp. Ther. 140, 349 (1963b).
Sutter, M. C.: The pharmacology of isolated veins. Brit. J. Pharmacol. 24, 742 (1965).
Tewksbury, D. A.: Studies on the mechanism of bradykinin potentiation. Arch. int. Pharmacodyn. 173, 426 (1968).
Tiirker, K., Kiran, B. K., Kaymakcalan, S.: The effects of synthetic bradykinin on intestinal motility in different laboratory animals and its relation to catecholamines. Arch. int. Pharmacodyn. 151, 260 (1964).
Walaszek, E. J., Dyer, D.: Polypeptide receptor mechanism: Influence of pH. In: Hypotensive spolypeptide, p. 329, ed. by E. G. Erdös, N. Back, and F. Sicuteri. BerlinHeidelberg-New York: Springer 1966.
Walaszek, E. J., Dyer, D., Gascon, A. L.: Polypeptide receptor mechanisms. Fed. Proc. 27, 67 (1968).
Walaszek, E. J., Huggins, C. G.: Substance A: A hypertensive polypeptide from Fraction IV-4 of plasma protein. J. Pharmacol. exp. Ther. 126, 258 (1959).
Walaszek, E. J., Huggins, C. G., Stmt, C. M.: Drugs that modify actions of pharmacologically active polypeptides. Ann N Y Acad. Sci. 104, 281 (1963).
Walaszek, E. J., Potter, D. E.: Amino acid derivatives: An approach to the study of potentiation and antagonism of pharmacologically active polypeptides. Pharm. Res. Comm. 1, 204 (1969).
Werle, E.: Zur Kenntnis des Haushalts des Kallikreins. Biochem. Z. 269, 415 (1934).
Werle, E.: Die Wirkung des Kallikrein (=Padutin) auf den isolierten Darm. Klin Wschr. 15, 848 (1936).
Werle, E.: The chemistry and pharmacology of kallikrein and kallidin. In: Polypeptides which stimulate plain muscle, p. 20, ed. by J. H. GADDUM. Edinburgh: E. & S. Livingstone 1955.
Werle, E., Götze, W., Keppler, A.: Über die Wirkung des Kallikreins auf den isolierten Darm und über eine neue darmkontrahierende Substanz. Biochem. Z. 289, 217 (1937).
Wiegerhaiisen, B., Stopp, G., Eichstädt, M.: Zum Mechanismus der Bradykininwirkung am Meerschweinchendarm. Acta biol. med. germ. 12, 443 (1964).
Winkler, H., Bauer, G., Gmeiner, R.: Zur Wirkung von Bradykinin, Kallidin und Eledoisin auf den Katzen-und Kaninchen-Darm in situ. Naunyn-Schmiedebergs Arch. exp. Path. Pharmak. 250, 459 (1965).
Zar, M. A.: Factors influencing the output of acetylcholine. D. Phil. Thesis. University of Oxford (1966).
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1970 Springer-Verlag Berlin · Heidelberg
About this chapter
Cite this chapter
Walaszek, E.J. (1970). The Effect of Bradykinin and Kallidin on Smooth Muscle. In: Erdös, E.G., Wilde, A.F. (eds) Bradykinin, Kallidin and Kallikrein. Handbook of Experimental Pharmacology / Handbuch der experimentellen Pharmakologie, vol 25 / 25. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-46222-1_20
Download citation
DOI: https://doi.org/10.1007/978-3-642-46222-1_20
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-46224-5
Online ISBN: 978-3-642-46222-1
eBook Packages: Springer Book Archive